Memorial Sloan Kettering surgeon Alice Wei

Alice Wei, MD, MSc, FRCSC, FACS

Surgeon

Titles

Co-Director, Surgical Initiatives, David M. Rubenstein Center for Pancreatic Cancer Research

Clinical Expertise

Disease of the Liver, Bile Ducts, Gallbladder, and Pancreas; Pancreatic Cancer; Pancreatic Cysts; Liver Metastases; Gastrointestinal Neuroendocrine Tumors; Ablation Therapy

New Patient Appointments

Scheduling a visit is easy. Click below or call us to get started.

Accepted Insurance Providers

Dr. Wei accepts the following list of insurance providers. Select your insurance provider to see more details.

Contact and Location

Locations map

Find a Convenient Location

Memorial Sloan Kettering has locations throughout New York City, Long Island, New Jersey, and Westchester. These locations offers many services, including screening, chemotherapy, and medical testing.

About Me

Education

MD CM, McGill University; MSc, Cell Biology, University of Toronto; MSc, Clinical Epidemiology, University of Toronto

Residencies

General Surgery – University of Toronto

Fellowships

Hepatobiliary and GI Transplantation – Toronto General Hospital, University of Toronto

Board Certifications

Surgery (US); General Surgery (Canada)

I am a surgeon who specializes in treating diseases of the liver, bile duct, gallbladder, and pancreas. I have special expertise in using minimally invasive methods, such as laparoscopic and robotic surgery. I also do ablation therapy. This uses special needles to apply heat, cold, lasers, or chemicals to destroy cancer cells. I am proud to be part of a multidisciplinary team that provides outstanding care to people with cancer.

Before coming to MSK, I worked at a leading cancer center in Canada. I was one of the most experienced surgeons in the country treating hepatobiliary cancers and I consider it a privilege to help people through a very difficult time in their life. When it comes to cancer care, the best treatment is specific to that person. It is incredibly meaningful to guide people through treatment, to help them determine which of the established or perhaps new treatments is best suited to them.

The patients I see often feel anxiety from fear of the unknown. I think the best way to reassure them is to be as knowledgeable as possible about their condition so they can feel confident they are receiving the best possible treatment for their disease.

I make sure to spend time answering any questions patients may have about what the future will hold. I like to ask people at the end of the visit, “Is that what you expected to hear from me?” This gives them a chance to tell me what they were thinking before they came. When they finish treatment, I hope they feel that they received the best care for their situation.  

In addition to caring for patients, I conduct research on ways to make cancer surgery even more effective. I have helped develop strategies to improve the quality of care for people after complex surgery. I have also advised on health policies to guide doctors and to provide policymakers with the most up-to-date cancer knowledge.

In my spare time, I spend as much time as possible enjoying the company of my husband and kids. 

It is incredibly meaningful to guide people through treatment, to help them determine which of the established or perhaps new treatments is best suited to them.

Dr. Wei

Colleagues

Doctors at Memorial Sloan Kettering work as teams, with specialists from all different areas. This allows us to consider all your needs together, and to give you the best possible care.

Clinical Trials

Smiling doctors in the lab

Find a Clinical Trial for You

Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.

You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.

Research and Publications

Conroy T, Hammel P, Hebbar M, Ben Abdelghani M, Wei AC, Raoul J-L, Chone L, Francois E, Artru P, Biagi JJ, Lecomte T, Assenat E, Faroux R, Ychou M, Volet J, Sauvanet A, Breysacher G, De Fiore F, Cripps X, Kavan P, Texereau P, Bouhier-Leporrier K, Khemissa-Akouz F, Legoux J-L, Juzyna B, Eng S, O’’Callaghan C, Jouffroy C, Rat P, Malka D, Castan F, Bachet J-B. FOLFIRINOX versus Gemcitabine as Adjuvant Therapy for Pancreatic Cancer. N Engl J Med. 2018;379:2395-2406.

Wei AC, Coburn NG, Devitt KS, Serrano PE, Moulton CA, Cleary SP, Law C, Moore MJ, Gallinger S. Survival Following Resection of Intra- and Extra-Hepatic Metastases from Colorectal Cancer: A Phase II Trial. Ann Surg Oncol. 2016;23(8):2644-51.

Serrano PE, Herman JM, Griffith KA, Zalupski MM, Kim EJ, Bekaii-Saab TS, Ben-Josef E, Dawson LA, Ringash J, Wei AC. Quality of life in a prospective, multicenter phase 2 trial of neoadjuvant full-dose gemcitabine, oxaliplatin, and radiation in patients with resectable or borderline resectable pancreatic adenocarcinoma. Int J Radiat Oncol Biol Phys. 2014;90(2):270-7.

Wei AC, Sandhu L, Devitt KS, Gagliardi AR, Kennedy ED, Urbach DR, Gallinger S, Baxter NN. Practice patterns for the management of hepatic metastases from colorectal cancer: a mixed methods analysis. Ann Surg Oncol. 2013;20(5):1567-74

Publications on PubMed

Visit PubMed for a full listing of Dr. Wei’s journal articles. Pubmed is an online index of research papers and other articles from the US National Library of Medicine and the National Institutes of Health.